Contera Pharma: Clinical Trials

1 trial sponsored by Contera Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Contera Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
JM-010 group A, JM-010 group B, Placebos - Dyskinesias
Phase 2CompletedContera Pharma892019-07-222024-06-17

Conditions studied

Dyskinesias (1)

Countries

France (1)  ·  Germany (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)

Results publications

PMID 31356217

NIH funding

2017 (1)